What is the recommended dosing for diazoxide (intravenous) in treating acute hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diazoxide Dosing for Acute Hypoglycemia

For intravenous diazoxide in treating acute hypoglycemia, the recommended dosage is 3-5 mg/kg administered as an infusion at a rate of 15 mg/minute (maximum total dose of 5 mg/kg body weight). 1, 2

Dosing Protocol

  • Initial dose: 3 mg/kg IV infused at a rate of 15 mg/minute 1, 2
  • Maximum dose: 5 mg/kg total body weight 1, 2
  • Administration method: Slow infusion preferred over bolus injection to achieve more gradual blood pressure reduction and minimize adverse effects 2
  • Duration: Continue until blood glucose stabilizes or until maximum dose is reached 1

Clinical Considerations

Patient Monitoring

  • Monitor blood glucose levels every 15-30 minutes during infusion 1
  • Monitor blood pressure continuously during administration due to potential hypotensive effects 2
  • Assess for fluid retention and pulmonary complications, particularly in patients with cardiac conditions 3, 4

Efficacy Assessment

  • Therapeutic response should be evident within 25 minutes with infusion method 2
  • If no response is observed after reaching maximum dose, alternative treatments should be considered 1

Specific Populations

  • Pediatric patients: Start at lower end of dosing range (3 mg/kg) 1, 5
  • Patients with cardiac conditions: Use with extreme caution due to increased risk of pulmonary hypertension 3
  • Pregnant patients with hypertension: Infusion method (15 mg/minute) is preferred over bolus administration 2

Precautions and Contraindications

  • Fluid restriction: Total fluid volume should not exceed 130 mL/kg/day prior to and during diazoxide treatment to reduce risk of pulmonary hypertension 3
  • Cardiac screening: Consider echocardiography before initiating treatment in high-risk patients 3
  • Concomitant medications: Use caution when administering with other antihypertensive medications due to additive effects 2

Adverse Effects to Monitor

  • Fluid retention and edema (most common) 3, 4
  • Hypotension (may be severe with rapid administration) 2
  • Pulmonary hypertension (occurs in approximately 7% of patients) 3
  • Congestive heart failure (particularly with higher doses or prolonged use) 4

Alternative Treatments

If diazoxide is ineffective or contraindicated, consider:

  • Glucose administration (D10W: 200 mg/kg or 2 mL/kg) 1
  • Glucagon: 0.03 mg/kg up to maximum of 1 mg; may repeat every 15 minutes up to 3 doses if needed 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.